Mangafodipir (trisodium)
Product Sizes
100 mg
£ POA
HY-B0993-100MG
50 mg
£ POA
HY-B0993-50MG
5 mg
£ POA
HY-B0993-5MG
25 mg
£ POA
HY-B0993-25MG
10 mg
£ POA
HY-B0993-10MG
10mM/1mL
£ POA
HY-B0993-10MM
About this Product
- SKU:
- HY-B0993
- Additional Names:
- MnDPDP
- CAS Number:
- 140678-14-4
- Extra Details:
- Mangafodipir trisodium (MnDPDP); hepatocellular-specific contrast agent; is an efficacious inhibitor of CIPN (chemotherapy-induced peripheral neuropath) and other conditions caused by cellular oxidative stress. Mangafodipir trisodium shows no negative interference with the tumoricidal activity of chemotherapy[1][2].
- Molecular Weight:
- 757.32
- Purity:
- 99.82
- References:
- [1]Karlsson JOG, et al. Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN). Transl Oncol. 2017 Aug;10(4):641-649. |[2]Wang C. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Acta Radiol Suppl. 1998;415:1-31.|[3]Qin Y, et al. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice. Reprod Biol Endocrinol. 2018 Oct 27;16(1):106.
- Research Area:
- Neurological Disease; Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; sealed storage; away from moisture)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Apoptosis
